Search Results for grant - Grants:
No. Item
GRANTS
1. Ahsan F. A., Kwon Y. M., Chemically Modified Heparin for Reduced Incidences of Heparin-induced Thrombocytopenia (Not funded)., National Institutes of Health, $275000, 2011 - 2013.
2. Alvarez, G., Gift-in-Kind : donation hard-ware and soft-ware computer systems for patient care management labs, QS1, $18000, 2016 - 2016.
3. Alvarez, G., Antidepressant Medication Adherence in a University Based Community Pharmacy Practice Environment – Outcomes of a Pharmacist Intervention Program, Pfizer, $5000, 2004 - 2004.
4. Alvarez, G., Scholastic Achievement w/ Community Pharmacy Service/Interest, Rx Systems Scholarship, $3000, 2004 - 2004.
5. Alvarez, G., Osteoporosis -Risk Assessment Based on Ethnic Background, Novartis: Research Project, $6000, 2002 - 2002.
6. Alvarez, G.(PI), Pharmacist Enhancement of Treatment Decision Making at the Point- of- Care in Type II Diabetes Patients, Amylin-Lilly Grant , $50000, 2012 - 2012.
7. Alvarez, G., & Lafferty, L., Development of an Integrative Pharmacy and Herbal Therapy course, Standard Process Grant , $25000, 2016 - 2016.
8. Alvarez, G., & Lafferty, L., Development of an Integrative Pharmacy and Herbal Therapy course, Standard Process Grant, $10000, 2016 - 2016.
9. Alvarez, G., & Lai, L., Pharmacist Advocate Program, OptumRx Grant , $810000, 2017 - 2020.
10. Alvarez, G.,Clauson, K., McLaughlin, J., & Borja, N., Interventional Study of Text Messaging to Improve Medication Adherence in T2DM, NSU Chancellor’s Faculty Research and Development Grant , $10000, 2011 - 2012.
11. Ana Castejon, Deth R, Metabolic and nutritional impact of casein and gluten-derived exorphin peptides in autism, Autism Speaks, $1363193, - .
12. Ana Castejon, Deth R, Novel Cell Death Mechanisms in Autism, NIH R15, $353842, - .
13. Ana Castejon, Deth R, Follow up studies for Immunocal project, Immunotec Inc., $76746, - .
14. Ansari, R.A., None, Regulation of Human Angiotensinogen Gene by Ethanol, Health Professions Division, $5000, 2010 - 2011.
15. Ansari, R.A., Development of in vitro models for studying the xenobiotics potential for regulation of human angiotensinogen, Alternate Research Development Foundation, $20000, - .
16. Ansari, R.A., None, Global Senior Scholar Exchange Program -Host Application (Not awarded), Society of Toxicology, $15000, 2017 - 2018.
17. Ansari, R.A., None, Global Senior Scholar Exchange Program-Host application (Not awarded), Society of Toxicology, $15000, 2016 - 2017.
18. Ansari, R.A., None, Cell based model for studying the human angiotensinogen gene regulation after ethanol and cytokines (Not awarded), Alternate Research & Development Foundation, $40000, 2017 - 2017.
19. Ansari, R.A., None, Hypoxia Inducible Factor mediated human angiotensinogen gene regulation., President's Faculty Research & Development Grant, $15000, 2015 - 2017.
20. Ansari, R.A., Saleem Khan, Regulation of human angiotensinogen gene after ethanol (not funded), NIH, $100000, 2011 - 2014.
21. Ansari, R.A., Robert Speth Saleem Khan, Regulation of human angiotensinogen gene after ethanol (not funded), NIH, $100000, 2012 - 2015.
22. Ansari, R.A., None, Role of cytokines in regulation of human angiotensinogen gene after ethanol (not funded), PhRMA, $60000, 2011 - 2012.
23. Ansari, R.A., None, Regulation of human angiotensinogen gene after ethanol (not funded), Alcohol Foundation (ABMRF), $50000, 2012 - 2014.
24. Ansari, R.A., None, Regulation of human angiotensinogen gene after ethanol (not funded), Alcohol Foundation (ABMRF), $50000, 2011 - 2013.
25. Ansari, R.A., None, Interleukin-1beta mediated human angiotensinogen gene regulation (not funded), President's Grant, $10000, 2012 - 2013.
26. Ansari, R.A., None, Role of AP-1 in regulation of human angiotensinogen gene after ethanol (not funded), President's Grant, $10000, 2011 - 2012.
27. Ansari, R.A., None, Regulation of human angiotensinogen gene by alcohol mediated hypoxia (not funded), Chancellor's pfrdg, $10000, 2010 - 2011.
28. Ansari, R.A., None, Role of ethanol and interleukin-1ß on angiotensinogen gene in cell based model system, Health Professions Division, $5000, 2012 - 2013.
29. Appu Rathinavelu, Kasyan-Itzkowitz, P., Maniscalco, M., Lipshutz, E., Daniel, K., Kelleher, W., Wichert, M., Marsh, W., Personal Empowerment via a Multidisciplinary Diabetes Education Program, President's Faculty Research and Development Grant, $10000, 2004 - 2005.
30. Appu Rathinavelu, Thiagarajan Venkatesan, Evaluating Gene Expression Profile of MDM2 Related Genes for Predicting Metastatic Potential, NCI - R21 (Not Funded), $274479, 2015 - 2017.
31. Appu Rathinavelu, Sivanesan Dhandayuthapani, Studies with Phycocyanin and Anticancer Drug Combinations, NCI - R15 (Not Funded), $381277, 2015 - 2018.
32. Appu Rathinavelu, Establishing the Safety of JFD, A New Antiangiogenic Drugs, Community Foundation of Broward, $50000, 2014 - 2015.
33. Appu Rathinavelu, Enhancing Therapeutic Potential of Anticancer Drugs using Phycocyanin, NSU, $10000, 2013 - 2015.
34. Appu Rathinavelu, Praneetha Muthumani, Umadevi Kandalam, Joseph Morrissey, James Kumi Diaka, Miroslav Gantor, Developing a Cell Sorting facility at NSU, Bankheadcoley - Florida Cancer Research Program , $450000, 2010 - 2010.
35. Appu Rathinavelu, Standardization of Gene Expression Array analysis using Rapidly Growing Cancer Cells, PFRDG - NSU, $10000, 2002 - 2004.
36. Appu Rathinavelu, Regulation of VEGF Expression by MDM2 Oncoprotein, NCI (Not funded) , $150000, 2006 - 2008.
37. Appu Rathinavelu, Studies on the Regulation of VEGF Expression by MDM2 Oncoprotein, NCI (Received Priority Score), $150000, 2008 - 2010.
38. Appu Rathinavelu, Identification and Validation of intracellular Targets for Cancer, State of Florida Department of Education, $100000, 2004 - 2006.
39. Appu Rathinavelu, Standardization and Application of Real Time PCR Technique in Gene Expression Analysis, PFRDG - NSU, $10000, 2004 - 2005.
40. Appu Rathinavelu, President's Faculty Research & Development Grant, PFRDG - NSU, $10000, 2006 - 2008.
41. Appu Rathinavelu, Preparation of Peripheral Mononuclear cells from Human Blood Samples, Spaltudag, $40000, 2007 - 2009.
42. Appu Rathinavelu, Leung S. , Poulakos M.N., The Role of P-glycoprotein in the Intestinal Transport of Posaconazole in CaCO2 Cell Line, NSU HPD Grant, $5000, 2009 - 2010.
43. Appu Rathinavelu (Research Mentor), Chinnaiyan Aiavu (Recipient of the Fellowship), Obama – Singh 20th Century Knowledge Initiative Grant, University Grants Commision of India, $30000, 2013 - 2014.
44. Atangana E, Warner DG, Reyna GG, Martinez O, Benavides S (consultant), Caballero J (consultant), Border health education internet access., National Library of Medicine (NLM) (AWARDED), $157000, 2006 - 2008.
45. Ayman M. Saleh, Syed A. A. Rizvi, Isolation, Characterization and Evaluation of the Natural Anti-Cancer Drugs from the TSS Plant and assessing their potential Effects in Treating Prostate Cancer, Hess-Roth Kaminski & Maxon Foundation of Erie, Pennsylvania, $15000, 2010 - 2011.
46. Basu, A., Latimer, J.J., TNF-Signaling in Breast Cancer., U.S. National Institutes of Health/National Cancer Institute , $375016, 1997 - 2002.
47. Benavides S, Caballero J, Clauson K, Segal D, Implementation of a web-based virtual reality patient case-based learning managment system in the College of Pharmacy., Nova Southeastern University Health Professions Division Chancellor's Educational Research Grant (AWARDED), $10000, 2010 - 2012.
48. Benavides S, Howe DE, Parent and children's perceptions of obesity and risk of disease., University of Texas Pan American Undergraduate Research Initiative (AWARDED), $1500, 2004 - 2005.
49. Benavides S, Granberry M, Lacar E, Faraji B, The effect of participation in middle school basketball on markers of insulin resistance and inflammation in adolescents., American Diabetes Association (NOT FUNDED), $53900, 2004 - 2004.
50. Benavides S, Granberry M, Barner J, Self-perceptions of obesity and knowledge of associated health complications in Hispanic adolescents., Center for Medicare and Medicaid Services (NOT FUNDED), $239690, 2004 - 2004.
51. Benavides S, Clinical outcomes in a medically underserved community., University of Texas Pan American Faculty Research Council (NOT FUNDED), $2850, 2004 - 2004.
52. Benavides S, Briones E, Chterba S, Diabetes self managment in a Hispanic Population., National Intitutes of Health, National Institute of Nursing Research (NOT FUNDED), $388402, 2004 - 2004.
53. Benavides S, Kelder SH, Sugunan U, Insulin resistance in obesity, prediabetes, and diabetes in children: When will the complications begin?, US Hispanic Nutrition Research and Education Center (AWARDED), $49918, 2004 - 2006.
54. Benavides S, Caballero J, Sugunan U, Acanthosis nigricans in hispanic children and adolescents., UTPA-NIH Sponsored Research Infrastructure Program (DEFERRED), $5994, 2005 - 2005.
55. Benavides S, Caballero J, Sugunan U, Acanthosis Nigricans in Hispanic Children and Adolescents., Minority Biomedical Research Support (SCORE). National Institutes of Health (NOT FUNDED), $116320, 2005 - 2005.
56. Benavides S, Pharmacists in the prevention of obesity., Robert Wood Johnson Foundation (NOT FUNDED), $54500, 2006 - 2006.
57. Benavides S, Caballero J, Salazar J, Kim G, Yoga for the wellness of children., The University of Texas-Pan American, Faculty Research Council Award (AWARDED), $3050, 2006 - 2006.
58. Benavides S, DeLeon JM, Exantus M, Identifying obesity and obesity related complications in pediatrics., NSU Quality of Life Faculty Community-Based Applied Research Grant (AWARDED), $10000, 2010 - 2012.
59. Benavides, S., Granberry, M., Lacar, E., Faraji, B., Insulin resistance and inflammatory markers in athletes., University of Texas Pan American and National Institutes of Health Sponsored Research Infrastructure Program (OBRR5-01), $5400, 2004 - 2004.
60. Bigbee, W.L., Keohavong, P., & Grant, S.G., Lifestyle Factors Affecting Fetal Somatic Mutation., National Institutes of Health, $2680786, 1996 - 2001.
61. Boylan, P., Eltaki, S., Development of transitions of care pharmacist services for high-risk medical patients in a tertiary community hospital discharge unit, American Society for Health-System Pharmacist's Foundation, $5000, 2016 - 2017.
62. C Bertol, L Grando, R Santos, A Pasqualoti, E Liberti, H Omidian, Ozonized Oil: Characterization, Placebo Controlled Triple Blind Clinical Trial, Determination of the Mechanism of Action in Rats and Development of a New Formulation, CNPq (Conselho Nacional de Pesquisa e Desenvolvimento), $10000, 2018 - 2018.
63. C McLachlan, B Zhao, A Khoynezhad, R Whitbourn, T Steinke, KM Cherian, H Omidian, H Kiat, A Hydrogel for Cardia Vascular Surgery, Australian NHMRC Development Grant Application, $1700000, 2016 - 2016.
64. Caballero J, Medication adherence and executive control function in Hispanic patients with type 2 diabetes., UTPA Faculty Research Grant (AWARDED), $2280, 2005 - 2005.
65. Caballero J, Jacobs RJ, Thomas JE, Ownby RL, Schweizer M., Effects of type 2 diabetes on antiretroviral adherence in older adults with HIV., NSU President’s Faculty Research and Development Grant. (AWARDED), $10000, 2014 - 2015.
66. Caballero J, Thomas JE, Jacobs RJ, Ownby RL, Schweizer M., Effects of depression on antiretroviral adherence in emerging adults with HIV., NSU President’s Faculty Research and Development Grant. (AWARDED), $10000, 2014 - 2015.
67. Caballero J, Evaluation of medications used amongst low-income families., UTPA Faculty Research Council Award (AWARDED), $1600, 2006 - 2006.
68. Caballero J, Benavides S, Schillerstom J, Souffrant G, Executive control function and disease management in Hispanics, MBRS-Score Grant, National Institute of Health General Medical Sciences- sub-project (NOT FUNDED), $95144, 2005 - 2006.
69. Caballero J, Melnick I, Conversion of long acting injectable antipsychotics to Invega Sustenna, Ortho-McNeil Janssen Scientific Affairs Investigator Initiated Study- concept proposal (NOT FUNDED), $132188, 2010 - 2011.
70. Caballero J, Assessment of cognition and psychosocial issues in children with insulin resistance., Undergraduate Research Initiative Grant (AWARDED), $1500, 2005 - 2005.
71. Caballero J, Benavides S, Medication review and managment for colonia residents in Lower Rio Grande Valley., UTPA-NIH Sponsored Research Infrastructure Program (DEFERRED), $6100, 2005 - 2005.
72. Caballero J, Benavides S, Alternative therapy for depression in adolescents., Hispanic Health Research Center, University of Texas School of Public Health at Brownsville (NOT FUNDED), $30000, 2004 - 2004.
73. Caballero J, Pandya N, Ownby RL, The relationship of cognitive function on disease outcomes in elderly Hispanic patients with type 2 diabetes: a pilot study., Health Profession Division Research Grant, Nova Southeastern University. (AWARDED), $5000, 2010 - 2013.
74. Calderón, J (PI), Sangasubana, N (co-PI), Alvarez, G, & Rabionet, S., Diabetes Literacy and Self-Efficiency Screening and Training Project (Diabetes LASST), The Hispanic Health Services Research Grant Program of the Centers for Medicare and Medicaid Services (CMS) , $225000, 2008 - 2010.
75. Carmen D. Zorrila, Syed A. A. Rizvi, NIH Summer Research Experience., National Institute of Mental Health (NIMH), $500000, 2011 - 2011.
76. Carmen Zorrilla, Rabionet, S., Silva-Suarez, G., & Colon, M., Evaluate feasibility and acceptability by women and men living with HIV of administering HVST among their HIV-unknown status partners, and promoting PreP initiation among their HIV negative partners. (Pending subcontract with NSU), National Institutes of Mental Health, $100000, 2019 - 2020.
77. Carmen Zorrilla, Rabionet, S., Silva-Suarez, G., & Colon, M, U=U Message Dissemination and Adaptation: Educational Intervention to Stakeholders. (Pending subcontract with NSU), National Institutes of Mental Health, $100000, 2019 - 2020.
78. Carvajal, M., Rabionet, S., Perez, A., Armayor, G.M., Clauson, K., McLaughlin-Middlekauff, J., HPV vaccine acceptability by Hispanic parents living in South Florida; a comparison between different countries of origin. Award not granted, project not developed., Merck & Co., Inc., $0, 2009 - .
79. Castejon, A., Faillace, R., Kabot, S., Leiderman, R., Packer, E., Peters, B., & Sheinberg, N., Nutritional Intervention Using Supplementation with Cysteine-Rich Whey Protein Isolate (Immunocal®) in Children with Autism: Effects in Core Areas of Behavior- A Randomized Double-Blind Study, NSU and Immunotech Inc. Clinical Research Contract 2011-2013 (PI), Immunotech Inc. , $107000, - .
80. Castejon, A.M., Quantification of Glutathione in Blood Samples: A Biological marker for Autism?, , $5000, 2010 - .
81. Clark, M., Kandalam, U., and Haspula, D, Molecular Interactions Between Angiotensin II and Endocannabinoid Receptors, Presidents Faculty Research and Development Grant, $10000, 2013 - 2015.
82. Clark, M., Molecular Effects of Angiotensin II on Astrocytes Isolated from Hypertensive Rats, Presidents Faculty Research and Development Grant, $10000, 2010 - .
83. Clark, M., The Regulation of Growth by Angiotensin Peptides, AACP New Investigator Award Grant, $10000, 2002 - .
84. Clark, M., Regulation of Angiotensin II Receptors in Astrocytes Isolated from mRen2 Transgenic Rats., Florida Research on Cancer and Tobacco-related Diseases, $115629, 2003 - .
85. Clark, M., Molecular Effects of Angiotensin II on Astrocytes Isolated from Hypertensive rats., Presidents Faculty Research and Development Grant, $10000, 2011 - 2012.
86. Clark, M., Isolation and Characterizations of Neurons and Astrocytes from Rat Brains, Health Professions Division Research Grant, $5000, 2010 - 2012.
87. Clark, M., Kandalam, U., Angiotensin III Regulation of Mitogen Activated Protein Kinases in Astrocytes., Presidents Faculty Research and Development Grant, $10000, 2008 - 2009.
88. Clark, M., Angiotensinogen and ACE2 expression in cultured cerebellar and brainstem astrocytes of transgenic ren-2 newborn rats., Presidents Faculty Research and Development Grant, $10000, 2006 - 2007.
89. Clark, M., Dysregulation of AT1 Receptors in (mRen2)27 Transgenic Rats., The National Heart, Lung, and Blood Institute., $176000, 2004 - 2008.
90. Clark, M., Dysregulation of AT1 Receptors in (mRen2)27 Transgenic Rats., President’s Faculty Scholarship Award. , $10000, 2004 - 2005.
91. Clark, M., The Regulation of Astrocyte Growth by Angiotensin II., President’s Faculty Scholarship Award., $10000, 2002 - 2004.
92. Clark, M., The Regulation of Astrocyte Growth by Angiotensin II., Health Professions Division Research Grant, $5000, 2001 - 2003.
93. Clark, M.,, Haspula, D., Role of the CB1R in Ang II-induced Effects in SHR and Wistar Astrocytes., Health Professions Division Research Grant, $5000, 2014 - 2016.
94. Clark, M.,, Negussie, S., Lymperopoulos, A., Angiotensin II-mediated Signaling in Astrocytes: Role of Beta-arrestins., Presidents Faculty Research and Development Grant, $15000, 2016 - .
95. Clauson K, Elrod S, Sherman E, Garcia A, Pilot study to assess the impact of SMS/text messages on medication adherence for Type 2 diabetes., McKesson Foundation Mobilizing for Health Grant (AWARDED), $57000, 2011 - 2013.
96. Clauson KA, Singh-Franco D., Czerwinska J., Goncz C., Impact of a response system on communication apprehension in pharmacy students., President’s Faculty Research & Development Grant, $0, 2007 - .
97. Clauson, K, Perez A (Co-PI), Alvarez, G., Pandya, N., Lewis, D., Interventional study of text messaging to improve medication adherence in type 2 diabetes., Nova Southeastern University Chancellor's Faculty Research and Developement Grant, $10000, 2011 - 2014.
98. Clauson, K.A., Clay, P.G.,Glaros, A.G., Pilot, Observational Study to Assess the Frequency, Indications, Effectiveness and Types of Complementary Alternative Medicine (CAM) including Herbal and Natural Products Utilized in HIV infected versus non-HIV infected Medically-indigent and Minority pat, Society of Infectious Disease Practioners, $10150, - .
99. Clauson, K.A., Elrod, S.S., Eckardt, P.A., Alkhateeb, F.M., Garcia, A.S., Sherman, E.M., Pilot study to assess the impact of SMS/text messages on medication adherence for T2DM, McKesson Foundation, $57763, 2011 - 2014.
100. Clauson, K.A., Clinical Decision Support Tools: Analysis of Online Drug Information Databases., Elsevier Health Sciences/Gold Standard Inc., $5000, 2006 - 2007.
101. Clauson, K.A., Safety considerations and St. John's wort labels., Pharmavite LLC., $5000, 2007 - 2008.
102. Clauson, K.A., McQueen, C.E., Bryant, P.J., Study to Assess the Knowledge and Attitudes of Missouri Pharmacists Regarding Natural Products, Missouri Pharmacists Association, $2537, - .
103. Czerwinska, Jolanta M., someone, something, NIH, $2500, 2015 - 2015.
104. Czerwinska, Jolanta M., Some test grant, NIH, $300000, 2013 - 2015.
105. Czerwinska, Jolanta M., someone from COP, test grant, NIH, $2000, 2013 - 2015.
106. D Mastropietro, Opioid-Binding Agents to Deter Abuse of Prescription Drugs, American Association of Colleges of Pharmacy (AACP), $10000, 2016 - 2016.
107. D Mastropietro, H Omidian, Opioid-Binding Agents to Deter Abuse of Prescription Drugs, President’s Grant, Nova Southeastern University, $15000, 2016 - 2017.
108. Deth R, Malav Trivedi, Curtin Study: Impact of dietary A1 beta-casein on oxidative stress and methylation metabolite levels in human subjects fed an A1 vs. A2 diet, A2 Milk Corporation, $11400, - .
109. Deth R, Frank Tarazi, EPIGENETIC AND DEVELOPMENTAL CONSEQUENCES OF ANTIOXIDANT DEPLETION BY ENVIRONMENTAL AGENTS, , $1885095, - .
110. Deth R, Malav Trivedi, Simulated Gastric In-vitro Digestion (SGID) of A1, A2 Skim Milk Powder, A2 Milk Corporation, $35000, - .
111. Deth R, Malav Trivedi, EFFECTS OF BCM7 ON UPTAKE AND TRANSPORT OF ESSENTIAL MICRONUTRIENTS, A2 Milk Corporation, $28750, - .
112. Deth R, Malav Trivedi, Assessment of differences in gene expression and epigenetic status in F4 generation NOD mice receiving A1 vs.A2 casein diets, A2 Milk Corporation, $12000, - .
113. Deth, R, Castejon, A.M. (Co-PI), Metabolic and Nutritional Impact of Casein and Gluten-derived exorphin peptides in autism, Autism Speaks, $1363920, 2014 - .
114. Deth, R., Jonghan Kim, IN VITRO AND IN VIVO EFFECTS OF ALUMINUM AND THIMEROSAL ON ANTIOXIDANT AND EPIGENETIC STATUS: HOW VACCINE COMPONENTS CONTRIBUTE TO AUTISM RISK., CMSRI_SAFEMINDS, $150000, - .
115. Deth, R., Nancy Klimas, Testing the Model: A Phase I/II Randomized Double Blind Placebo Control Trial of Therapeutics: Liposomal Glutathione and Curcumin., , $512460, - .
116. Dittman, PW, Kleier, JA., Singh-Franco D., Levin, A., Colas M, Swann E, Petrosky S, Gordon AB., A Community-Based, Inter-Professional Diabetes Self Management Education Project., Nova Southeastern University, $10000, 2015 - 2016.
117. Dr. James T. Porter, Co-PI: Dr. Gregory J. Quirk (Medical Sciences Campus, UPR) Collaborator: Dr. Santini E. (NSU COP), Applying in vitro recording techniques to extinction of conditioned fear., National Science Foundation (NSF), $378729, 2009 - 2012.
118. Draper, DL, Latimer, JJ CO-I, Increased Metalloproteinase-9 Activity in Human Amniochorion Correlates with Preterm Premature Rupture of Membranes, March of Dimes (subcontract), $92000, 1996 - 1999.
119. Drs. Kimberly Sullivan and Maxine Krengel., Deth R, Examination of neuroimaging, cognitive functioning and plasma markers in a longitudinal cohort of Gulf War deployed veterans: The Ft. Devens Cohort, DoD, $55657, - .
120. Elrod S, Sherman E, At-home monitoring of blood pressure in hypertensive HIV-infected patients, NSU President's Faculty Research and Development Grant (NOT FUNDED), $10000, 2012 - 2013.
121. Eyambe GS, Briones E, Benavides S, Edionwe A, Friedman, B, Villas P, Wong W, Faraji B, DelToro I, Christian E, UT-Pan American-Rio Grande Valley Partnership Conference Series., National Institute of Child Health and Human Development (NICHD) (AWARDED), $90000, 2006 - 2009.
122. French, M., Popovici, I., Balsa, A., Fang, H., McLellan, T., Economic Consequences of Illicit Drug Use and Abuse., NIH (National Institute on Drug Abuse), $600000, - .
123. French, M., Popovici, I., McColister, K., Substance Abuse Treatment Costs in the State of Florida., Robert Wood Johnson Foundation (Substance Abuse Policy Research Program), $400000, - .
124. Gernant, S., Prados, Y., Development of a MTM Administration Certification for Pharmacy Technicians, Community Pharmacy Fundation, $42000, - .
125. Gernant, S.A., Eltaki, S.M., Development and Evaluation of Accountable Care Post-Graduate Training Programs for Pharmacists, American Society of Health Systems Pharmacists Research and Education Foundation, $75000, 2015 - 2017.
126. Gernant, S.A., Prados, Y., Can video-conferencing among patients, providers and pharmacists in an ACO improve medication related problem detection and resolution?, ASHP Foundation: Practice Advancement Demonstration Grant , $75000, 2016 - .
127. Gernant, S.A., Sanchez, J; Romeu, G., Creating bilingual pharmacy staff through distance rotations and Spanish pharmacy education, CVS Foundation, $248937, 2016 - .
128. Gernant, S.A., Eltaki, S., After the Community Pharmacy PGY1: Improving the quality and scope for post-graduate pharmacists, Community Pharmacy Foundation, $25000, 2016 - .
129. Gernant, S.A., Prados, Y, Development of a training program for pharmacy technicians/ student interns in MTM Administration., National Association of Chain Drug Stores Foundation, $19924, 2016 - .
130. Grant, S.G., & Latimer, J.J., Genotoxicity of Tamoxifen Adjuvant Therapy for Breast Cancer, American Cancer Society , $336614, 1998 - 2001.
131. Grant, S.G., Latimer, J.J., Detailed Molecular Profiling of Sporadic Stage I Breast Cancer, PFRDG NSU, $10000, 2014 - 2015.
132. Grant, S.G., Latimer, J.J., Molecular Mechanism of DNA Repair Deficiency in Breast Cancer, PFRDG NSU, $10000, 2012 - 2014.
133. Grant, S.G., & Latimer, J.J., Genetic Analysis of DNA Repair Deficiency in Novel Non-tumor Adjacent and Tumor Cell Lines suggests a New Paradigm of Breast Cancer Etiology., U.S. Army Medical Research and Material Command, $114000, 2004 - 2005.
134. Grant, S.G., & Latimer, J.J., Genetic basis of DNA repair deficiency in sporadic breast cancer., The Susan G. Komen Breast Cancer Foundation , $250000, 2004 - 2005.
135. Grant, S.G., & Latimer, J.J., Biomarkers of Invasive and Metastatic Potential in Breast Carcinoma in Situ., Friends for an Earlier Breast Cancer Test, $40000, 2008 - 2009.
136. Grant, S.G., & Latimer, J.J., Hypersensitivity to Tobacco Smoke Mutagens among BRCA Carriers, University of Pittsburgh Reduce Smoking and Exposure to Tobacco (ReSET) Center, $12000, 2008 - 2008.
137. Grant, SG, Latimer, JJ Co-I, Persistently Elevated Somatic Mutation as a Biomarker for Clinically Relevant., US Department of Defense, $581848, 2016 - 2020.
138. H Omidian, UD Kandalam, DJ Mastropietro, Smart Polymers to Reduce Alcohol Absorption into Systemic Circulation, 2012 Chancellor’s Grant: Nova Southeastern University, $10000, 2011 - 2013.
139. H Omidian, Hydrogel Cryogel Hybrids to Deter Prescription Drug Abuse by Injection and Insufflation, National Institute of Drug Abuse , $391213, 2017 - 2017.
140. H Omidian, Collective Adsorption, Absorption, Coagulation, Binding, and Aversion to Deter Prescription Drug Abuse via Injection, National Institute of Drug Abuse, $266222, 2017 - 2017.
141. H Omidian, S Muppalaneni, Y Joshi, and D Mastropietro, Medications Resistant to Abuse by Crushing and Hot Aqueous Extraction, President's grant, Nova Southeastern University, $10000, 2014 - 2015.
142. H Omidian, D Mastropietro, Engineering Approaches in Developing Abuse-Deterrent Medications, Nova Southeastern University, $5000, 2012 - 2014.
143. H Omidian, Tuning Polymer Viscoelasticity, Swelling, and Binding to Tackle Prescription Drug Abuse, National Science Foundation, $498702, 2016 - 2016.
144. H. Omidian, Pilot plant design to manufacture agricultural superabsorbents, Private Industry, $4500, 1998 - 2000.
145. H. Omidian, Expandable Platforms for Gastric Retention Applications., President's Grant, $10000, 2009 - 2011.
146. H. Omidian, Swellable Platforms for Gastric Retention, HPD, $5000, 2008 - 2010.
147. H. Omidian, Superabsorbents for Hygienic Applications, Private Industry, $5500, 2000 - 2001.
148. Hale G, Sando, K., Assessing students for practice-and team-readiness prior to an ambulatory care APPE., American Association of Colleges of Pharmacy, $10000, 2019 - 2020.
149. Hale G, Khanfar NM, Elharar, O., Nappi, R., Day for the Next Generation of Pharmacists., National Association of Chain Drug Stores (NACDS) Foundation Diversity Scholarship, $14605, 2019 - 2020.
150. Hale G, Maravent, S., Joseph, T., Alameddine, S., Stern, D.F., Stultz, K., Miller, J., Santiago-Nieves, A., Rodriguez, M., & Perez, A., Improving quality of life and cardiovascular health and wellness of elderly patients in South Florida., NSU Quality of Life Faculty Community Based Applied Research Grant, $10000, 2016 - 2017.
151. Hale G, Singh-Franco, D., Joseph T., Jacobs, R., & Hardigan, P., An evaluation of practitioners' preference of stroke risk in nonvalvular atrial fibrillation: CHA2DS2-VASc versus CHADS2., NSU Health Professions Division Research Committee, $7500, 2016 - 2017.
152. Hale G, Lymperopoulos, A., Joseph T., & Brill, A., Arg389Gly polymorphism in beta-1 adrenoreceptors for heart failure patients within the primary care setting., American College of Clinical Pharmacy, $14500, 2018 - 2019.
153. Hale G, Lymperopoulos, A., Joseph T, Simpson A, Zorrilla R, Kankam E, Choudhry A, Wertz S, Pollard C, Arg389Gly Polymorphism in Beta-1 Adrenoceptors for Heart Failure Patients within the Primary Care Setting., NSU President's Faculty Research and Development Grant, $13740, 2019 - 2020.
154. Hale, M., Su, HF., Masi, W., Kabot, S., Kaplan, M., Lai, L., Project A+ (Autism+Mathematics=Communication)., Nova Southeastern University President’s Annual Faculty Research and Development Grant, $3000, 2006 - 2007.
155. Hale, M., Kabot, S., Kaplan,M., Lai, L., Masi, M., Packer, E., Reed, C., Su, HF., Project A+., Nova Southeastern University President’s Annual Faculty Research and Development Grant, $10000, 2005 - 2006.
156. Hannah, S., Hellman, M., Su, HF., Lai, L., An Exploratory Study of the Interrelationships Between Social Networks and Learning Communities., Nova Southeastern University President’s Annual Faculty, $1000, 2004 - 2005.
157. Hannah, S., Dringus, L., Deziel-Evans, L., Hellman, M., Lai, L., Thompson, T., Cohen, A., The Design of Collaborative Learning Environ-ments: Building Community on the Web., Nova Southeastern University President’s Annual Faculty Research and Development Grant, $1500, 2000 - 2001.
158. Harrington CA, Unger NR, Encouraging bilingualism (English/Spanish) in pharmacy students and practicing pharmacists in delivery of counseling services., CVS Corporate Giving, $30000, 2014 - .
159. Ioana Popovici, Hardigan, P. & Carvajal, M., Variability in response rate, bias, and cost-effectiveness in survey data collection among practicing pharmacists., Nova Southeastern University Health Professions Division, $5000, 2011 - 2013.
160. Ioana Popovici, Hardigan, P. & Carvajal, M., Variability in response rate, bias, and cost-effectiveness in survey data collection among practicing pharmacists., Nova Southeastern University Health Professions Division, $5000, 2011 - 2013.
161. Jacobs RJ, Ownby RL, Caballero J (co-Investigator), Acevedo-Cruz A., A culturally appropriate automated tailored information application for medication health literacy in Spanish speaking Hispanics., National Institutes of Health-R21 (NOT FUNDED, score 31), $357957, 2012 - 2013.
162. Jacobs RJ, Ownby RL, Caballero J, Cultural-linguistic adaptation of a health literacy intervention for Hispanics., Nova Southeastern Chancellor’s Faculty Research and Development Grant (AWARDED)., $10000, 2011 - 2013.
163. Jacobs RJ, Ownby RL, Caballero J (co-investigator), Acevedo-Cruz A,, A culturally appropriate automated tailored information application for medication health literacy in Spanish speaking Hispanics., National Institutes of Health R21 (RESUBMITTED 11/2011), $349248, 2012 - 2013.
164. Jennifer Gershman, Popovici, I., Fass, A., & Gershman, J., Evaluation of Florida Physicians’ Knowledge and Attitudes Toward Accessing the State Prescription Drug Monitoring Program as a Prescribing Tool., Nova Southeastern University Health Professions Division, $5000, 2012 - 2014.
165. Jesus Sanchez, A CBPR Approach to Capacity Building among Latino Migrant Workers to prevent HIV, President's Faculty Research and Development Grant, $10000, 2012 - 2014.
166. Jesus Sanchez, Claudia Serna, Assessing Factors Associated with Transition to Injection among Heroin Users, NSU's PFRDG, $14979, 2018 - 2020.
167. Jesus Sanchez, Assessing high risk sexual behaviors among users of a gay sex mobile application, NSU's PFRDG, $15000, 2015 - 2017.
168. Jesus Sanchez, HIV Risk Reduction in High Risk Latina Migrant Workers in South Florida, National Institute on Minority Health and Health Disparities, $897851, 2012 - 2017.
169. Jesus Sanchez, Building Capacity and Infrastructure in the Migrant Farm Worker Communities in South Florida, National Institute on Minority Health and Health Disparities, $420545, 2009 - 2011.
170. Johnson, J., Latimer, J.J., Molecular Mechanism of Nucleotide Excision Repair Deficiency in Novel Breast Tumor Cell Lines., Pre-Doctoral Award, U.S. Department of Defense Congressionally Directed Breast Cancer Research, $18000, 2002 - 2005.
171. Johnson, M.D., Richens, D.T., Crans, D.C., Rawas-Qalaji, M.M., Reverse Micelles as Metallodrug Stabilizing Delivery Platforms. (Not Funded), National Institute of Health (NIH), $300000, 2013 - 2016.
172. Jonghan Kim, Deth R, Neurochemical and Epigenetic Features of Perinatal Manganese Exposure [Subcontract]., , $617650, - .
173. Joseph, T, Seamon, M, 2017 Pharmacy Residency Expansion Grant PGY2 Ambulatory Care, American Society of Health-System Pharmacists, $25000, 2017 - 2018.
174. Kallidaikurichi V. Venkatachalam, Syed A. A. Rizvi, Cancer Gene Therapy: Targeting Cancer Cell Metabolism, resident’s Faculty Research and Development Grant (PFRDG): Nova Southeastern University, $10000, - .
175. Kandalam, U., Clark, M., Role of the JAK2/STAT Pathway in Angiotensin II Signaling in Rat, Presidents Faculty Research and Development Grant, $10000, 2007 - 2008.
176. Kandalam, U., Clark, M., Curcumin Induced Osteogenesis of Human Gingival Stem-Cells: Role of MAP Kinases, Presidents Faculty Research and Development Grant, $10000, 2013 - 2014.
177. Kandalam, U., Clark, M., In Vitro Evaluation of an Injectable Tissue-Engineered Nanocomposite Scaffold, Presidents Faculty Research and Development Grant, $10000, 2012 - 2013.
178. Kerstetter, D, Latimer, JJ, DNA repair in Elasmobranch Fishes to Assess Cancer Risk., Presidents's Faculty Research & Development Grant, $15000, 2016 - 2018.
179. Kerstetter, D, Latimer, JJ co-PI, DNA Repair in Elasmobranch Fishes to Assess Cancer Risk, President’s Faculty Research & Development Grant , $15000, 2017 - 2020.
180. Kevorkian, M., Latimer, J.J. Simco, G., STEM training grant, NSF Research Experience for Undergraduates, $300000, 2017 - 2019.
181. Kevorkian, M., Simco, G. Latimer, J. others, REU Site: Interdisciplinary Research for Undergraduates (I-REU), National Science Foundation, $200000, 2015 - 2018.
182. Khanfar NM, Harrington C, Anderson HH, Cultural Differences in Leadership Styles of Pharmacists., Health Professions Division (HPD), $5000, 2011 - 2012.
183. Khanfar NM, Alameddine, S., Hale, G., Diou¬Labault, F., Alvarado, Z., & Paul¬Blake, C., Increasing awareness on the use of e-cigarettes in adolescents., The Community Pharmacy Foundation, $15000, 2017 - 2018.
184. Khanfar NM, Hale, G., Karadsheh, Y., Rares, J., Chowdhury, A., & Tavarez, D., Garriga, M., & Rivero, L., Integrating customized exercise and nutritional services into a community pharmacy setting for patients with or at risk of hypertension, diabetes and dyslipidemia., The Community Pharmacy Foundation, $30000, 2017 - 2018.
185. Khanfar NM, Genevieve Hale, PharmD, BCPS, Yezen Karadsheh, PharmD, Jonathan Rares, PharmD, Asif Chowdhury, PharmD., Denisse Tavarez, PharmD., Integrating Customized Exercise & Nutritional Services in the Community Pharmacy., Health Foundation of South Florida, $97622, 2018 - 2019.
186. Khanfar, N.M., Hale G, Karadsheh, Y., Rares, J., Chowdhury, A., & Tavarez, D, Integrating customized exercises & nutritional services in the community pharmacy., Health Foundation of South Florida, $97622, 2018 - 2019.
187. Kingston, H., Faber, S., Grant, S.G., & Latimer, J.J., Red Blood Cell Content of Inorganic and Organic Compounds in Children with Autism and Controls, The Teresa and H. John Heinz III Foundation/The Richard King Mellon Foundation, $40000, 2010 - 2012.
188. Kwon Y. M., Sultan M. H., Modulation of Insulin Release from Crystalline Basal Formulations using Injectable Matrix, Health Professions Division, Nova Southeastern University, $5000, 2015 - 2016.
189. Kwon Y. M., Yang V. C., Delivery System for Simultaneous Brain Tumor Imaging and Therapy (Not funded)., American Cancer Society (Postdoctoral Fellowship Grant), $124000, 2005 - 2007.
190. Kwon Y. M., Victor Y. C., Brain Drug Delivery for Parkinson's Disease (Not funded)., National Institute of Health (F32), $92000, 2004 - 2006.
191. Kwon Y. M., Targeted and triggered plasminogen activation for thrombolysis with reduced bleeding risk (R) (Not funded)., American Heart Association, $140000, 2011 - 2012.
192. Kwon Y. M., Targeted and triggered plasminogen activation for thrombolysis with reduced bleeding risk (Not funded)., Amerian Heart Association, $140000, 2010 - 2012.
193. Kwon, YM, Mahdi W., & Sultan, M., Biotin-Triggered Delivery of a Thrombolytic Drug for Potential Stroke Therapy, Nova Southeastern Univeristy, $10000, 2013 - 2015.
194. Kwon, YM, Mahdi, WA Clark, MA, Neuroprotective thrombolytic bioconjugate for ischemic stroke, Nova Southeastern University, $15000, 2017 - 2018.
195. Kwon, YM, Triggered Delivery System for Targeted Thrombolysis for Potential Stroke Therapy (Not Funded), American Association of Colleges of Pharmacy (AACP) - New Investigator Award, $10000, 2014 - 2014.
196. Kwon, YM, Design of the Delivery System for Local Thrombolysis, Health Professions Division, Nova Southeastern University, $5000, 2012 - 2015.
197. L.Nathanson, M.Trivedi., Beljanski, V. B., Effect of ME/CFS on epigenetic regulation in specific immune cell types., Non-profit organization Solve ME/CFS Initiative, $32000, 2018 - 2019.
198. L.Nathanson, M.Trivedi, Genomic approach to find novel biomarkers and mechanisms of CFS/ME. Administrative Supplement to Existing NIH Grants and Cooperative Agreements., NIH NINDS, $110000, 2016 - 2017.
199. L.Nathanson, M.Trivedi, Genomic Approach to Find Female-Specific Mechanisms of GWI Pathobiology., DOD USAMRAA, $666819, 2017 - 2020.
200. L.Nathanson, M.Trivedi., Beljanski, V., Klimas, N., Fletcher, M., Baranuik, J., Immunomodulation in GWI., DOD USAMRAA, $732161, 2018 - 2021.
201. Lai, L., Huang, HF., Tan, MH., Off-Label Antidepressant Use in Treatment of Insomnia., Nova Southeastern University Chancellor’s Annual Faculty Research and Development Grant, $10000, 2011 - 2012.
202. Lai, L., Yang T., Bai S., Sanabria S., Trend of Nanomedicine Prescription in the United States, NSU President Faculty Research and Development Grant, $10000, 2014 - 2015.
203. Lai, L., Gharib, S., Huang, HF., Impact of Drug Interactions on Angiotensin Converting Enzyme (ACE) Inhibitors in the United States, 2001 to 2003, Nova Southeastern University President's Faculty Research & Development Grant , $10000, 2006 - 2007.
204. Lai, L., Chen, LC., Boyar, J., Sociodemographic Patterns of Insomnia Drug Prescription., Nova Southeastern University Chancellor’s Annual Faculty Research and Development Grant, $10000, 2009 - 2011.
205. Latimer J, Khanfar, NM, Genomic instability in blood cancers., Children's Leukemia Research Association, $10000, 2013 - 2013.
206. Latimer, J, Khanfar NM, Elevated Nucleotide Excision Repair: A biomarker for relapse in Childhood Acute Lymphocytic Leukemia., Children's Leukemia Research Association, $20000, 2015 - 2016.
207. Latimer, J. J., A pilot study to address DNA Repair Modulation by the circadian clock: A mechanism to prevent breast cancer., Florida Breast Cancer Research Foundation, $100000, 2019 - 2020.
208. Latimer, J.J., Jennifer Johnson (M.D. Ph.D. student), Molecular Mechanism of Nucleotide Excision Repair Deficiency in Novel Breast Tumor Cell Lines., Komen for the Cure Award, $90000, 2004 - 2007.
209. Latimer, J.J., Grant, S.G. Broderick, G. Hardigan, P., What Makes Breast Susceptible to Cancer Development: study of repair capacity of the human breast with consumer products chemical testing of early thelarche, Department of Defense CDMRP, $350000, 2014 - 2016.
210. Latimer, J.J., Impact of Environmental Xenoestrogens on Precocial Puberty and Breast Cancer., VFW of Pennsylvania Ladies Auxiliary Cancer Research Award, $20000, 2010 - 2012.
211. Latimer, J.J., The Impact of Environmental Xenoestrogens on African American Breast Cancer., The Pittsburgh Foundation, $150000, 2009 - 2011.
212. Latimer, J.J., Characterization of Unique Human Ductal Carcinoma in Situ (DCIS) Cell Lines for Identification of Biomarkers of Early Breast Oncogenesis and Progression., U.S. National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering , $25000, 2006 - 2009.
213. Latimer, J.J., A New Paradigm for African-American Breast Cancer Involving Stem Cell Differentiation in a Novel Human Mammary Epithelial Culture System., The Susan G. Komen Breast Cancer Foundation, $200000, 2006 - 2009.
214. Latimer, J.J., Koty, Breast Cancer Prevention by Apoptosis Induction in DCIS using Breast Ductal Lavage., U.S. Department of Defense Congressionally Directed Breast Cancer Research Program , $114000, 2005 - 2007.
215. Latimer, J.J., Evaluation of Environmental Agents for Prevention of Breast Cancer using a Novel Tissue Engineering System for Human Breast., The Susan G. Komen Breast Cancer Foundation, $100000, 2005 - 2008.
216. Latimer, J.J., Identification of Stem Cells in a Novel Human Mammary Epithelial Culture (HMEC) System that Reproducibly Demonstrates Ductal Organotypic Architecture., U.S. Department of Defense Congressionally Directed Breast Cancer Research Program, $114000, 2004 - 2006.
217. Latimer, J.J., Genetic Analysis of DNA Repair Deficiency in Novel Non-Tumor Adjacent and TumorCell Lines Suggests a New Paradigm of Breast Cancer Etiology., U.S. Department of Defense Congressionally Directed Breast Cancer Research Program, $114000, 2004 - 2006.
218. Latimer, J.J., Development of Live Cell Analysis as a Prognostic Tool for Early Stage Breast Cancer Recurrence., Jewish Healthcare Foundation of Pittsburgh, $90000, 2002 - 2004.
219. Latimer, J.J., Modulation of Mammary Epithelial Architecture in Vitro and SERM Testing., Pennsylvania Department of Health Breast Cancer Check-Off Awards, $35000, 2001 - 2002.
220. Latimer, J.J., Molecular Etiology of DNA Repair Deficiency in Novel Non-Tumor Adjacent and Tumor Cell Lines, U.S. Department of Defense Congressionally Directed Breast Cancer Research Program, $50000, 2001 - 2003.
221. Latimer, J.J., DNA Repair and Somatic Mutation in Breast Cancer., Pennsylvania Department of Health Breast Cancer Check-Off Awards , $25000, 1999 - 2000.
222. Latimer, J.J., Omar Ibrahim Stephen Grant, Validation of “miRRA”, a microRNA that lowers functional Nucleotide Excision Repair, as a therapeutic to lower drug resistance in late stage breast tumors., AutoNation, $150000, 2018 - 2021.
223. Latimer, J.J., Grant, SG Hardigan, P, Regulation of DNA (Nucleotide Excision) Repair in Breast Cancer to Create Windows of Tumor Vulnerability, PENDING: Breast Cancer Research Fund, $250000, 2020 - 2022.
224. Latimer, J.J., Stem Cells and DNA Repair in Childhood Leukemia, West Palm Beach Children’s Leukemia Research Association, $10000, 2011 - 2013.
225. Latimer, J.J., The context for ancestry in the breast cancer stem cell paradigm, NIH/NCI, $321651, 2012 - 2014.
226. Latimer, J.J., Grant, S.G. Broderick, G., Breast Epithelial Stem Cell Number and Potency in African American Women, PFRDG NSU, $10000, 2012 - 2014.
227. Latimer, J.J., Grant, S.G. Day, B.W., Novel Transformation Assay to Identify Florida Environmental Breast Carcinogens., PFRDG NSU, $10000, 2014 - 2015.
228. Latimer, J.J., Stone, E. Grant, S.G. Ibrahim, O., Regulation of DNA Repair in Treatment Resistant Breast Cancers to Create Windows of Tumor Vulnerability, Community Foundation of Broward (Pending Grant Proposal), $45000, 2015 - 2015.
229. Latimer, J.J., Grant, S.G. Hardigan, P., Ancestry and DNA repair in the stem cell paradigm of breast cancer and its translation into behavioral prevention, Charles and Esther King Foundation (pending grant proposal), $833000, 2015 - 2018.
230. Latimer, J.J., Grant, S.G. Broderick, G., Regulation of DNA Nucleotide Excision Repair in Breast Cancer to Create Windows of Tumor Vulnerability, Bankhead Coley, $400000, 2013 - .
231. Latimer, J.J., Grant, S.G., Human Breast Tissue Engineering Model for Environmental Chemical Testing., Florida Breast Cancer Foundation, $100000, 2012 - 2015.
232. Latimer, J.J., Hardigan, P., Witt-Enderby, P., Tartar, J., Grant, S., Nucleotide excision repair modulation by the circadian clock: A mechanism for prevention of breast cancer., DoD CDMRP, $375000, 2019 - 2022.
233. Latimer, J.J., NSU AutoNation Institute Breast Cancer Congress and Symposium, Florida Breast Cancer Foundation, $35000, 2018 - 2020.
234. Latimer, J.J., & Grant, S.G., A New Paradigm for African American Breast Cancer involving Stem Cell Differentiation in a Novel Culture System., U.S. Army Medical Research and Material Command, $114000, 2005 - 2006.
235. Latimer, J.J., Grant, S.G., The Role of DNA Repair, Genomic Instability and Stem Cells in Leukemia Relapse, National Children's Leukemia Research Association, Inc., $30000, 2012 - 2015.
236. Latimer, J.J., Grant, S.G., & Day, B.W., Biomarkers of Invasiveness in Racially Disparate Populations using an Isogenic and Progressive Model of Human DCIS., Komen for the Cure Foundation, $300000, 2007 - 2010.
237. Latimer, J.J., Use of a Unique 3-Dimensional Human Mammary Stem Cell Model to Determine the Role Of Environmental Xenoestrogens in African-American Breast Cancer Etiology., U.S. Department of Defense Congressionally Directed Breast Cancer Research Program, $114000, 2006 - 2008.
238. Latimer, J.J., A New Paradigm for African American Breast Cancer Involving Stem Cell Differentiation in a Novel Cell Culture System, U.S. Department of Defense Congressionally Directed Breast Cancer Research Program, $114000, 2005 - 2007.
239. Latimer, J.J., Day, B.W., & Grant, S.G., Quantitative Proteomics of Nuclear Matrix Proteins in Novel Human DCIS Model Systems, U.S. Department of Defense Congressionally Directed Breast Cancer Research Program, $800000, 2008 - 2010.
240. Latimer, J.J., DNA repair and breast cancer, U.S. National Institutes of Health/National Cancer Institute (R29 CA71894-O1A1), $335950, 1997 - 2002.
241. Latimer, J.J., Modulation of Mammary Epithelial Architecture in Vitro and SERM Testing, Pennsylvania Department of Health Breast Cancer Check-Off Awards, $35000, 2001 - 2002.
242. Latimer, J.J., Dan Focht, Bioptechs Inc., Development of Live Cell Analysis as a Prognostic Tool for Early Stage Breast Cancer Recurrence, Jewish Healthcare Foundation, $90000, 2002 - 2004.
243. Latimer, J.J., Genetic Analysis of DNA Repair Deficiency in Novel Non-Tumor Adjacent and Tumor Cell Lines Suggests a New Paradigm of Breast Cancer Etiology, U.S. Department of Defense Congressionally Directed Breast Cancer Research Program , $114000, 2004 - 2006.
244. Latimer, JJ, Temple, HT, DNA repair in childhood sarcoma, Sarah Canon Foundation, $200000, 2016 - 2018.
245. Latimer, JJ, Grant, SG Tartar, J, DNA repair as a biomarker for multiple clinically relevant exposures in Gulf War Illness, Department of Defense GWI, $230000, 2017 - .
246. Latimer, JJ, Omar Ibrahim Stephen Grant, Eradicating Drug Resistance by Targeting Breast Cancer Stem Cells Using miRRA., PFRDG, $15000, 2018 - 2020.
247. Latimer, JJ, Targeting African American and Ashkenazi Jewish Triple Negative Breast Cancers., Presidents's Faculty Research & Development Grant, $15000, 2016 - 2017.
248. Latimer, JJ, Grant, S.G. Klimas, N., Somatic Mutation and DNA Repair in Gulf War Illness., Presidents's Faculty Research & Development Grant, $15000, 2016 - 2017.
249. Latimer, JJ, Can DNA Repair Capacity in Breast Cancer Stem Cells Predict Recurrence?., Presidents's Faculty Research & Development Grant, $15000, 2016 - 2017.
250. Lazo, J., Grant, S.G., Macina, A., & Day, B.W., Combinatorial Approaches for Novel Anticancer Agents., National Institutes of Health, $3249685, 1998 - 2003.
251. Levin, A.D., Singh-Franco D., Gershman JA, Level of confidence and competence of immunization delivery by pharmacy interns who administer immunizations compared to pharmacy interns unable to immunize due to state law., National Association of Chain Drug Stores, $2500, 2015 - 2015.
252. Li, PF., Su, HF., Lai, L., Chen, PS., Ho, MH., Systemic Interventions of Project MIND (Math Is Not Difficult) and Solution Focused Brief Therapy for Children with Autism Spectrum Disorder and Their Families: A Pilot Study, The Chiang Ching-Kao Foundation, $15000, 2017 - 2018.
253. Lieb S, Sherman E, Clauson K, Unger N, Evaluation of Janssen Pharmaceutical's Care4Today Mobile Health Manager Program on ART Adherence (NOT FUNDED), Janssen, $360000, 2014 - 2016.
254. Lokshin, A., Latimer, JJ, Multiplexed Assay for Early Detection of Breast Cancer., , $250000, 2006 - 2008.
255. Lopez, J., Latimer, J.J. Grant, S.G., Genetic and Epigenetic effects of Oil/dispersant in marine invertebrate and human models of breast and blood, Gulf of Mexico Medical Research Institute, $748815, 2016 - 2018.
256. Lymperopoulos, A., Role of adrenal beta-arrestin-1 in angiotensin II-induced aldosterone production in post-infarct heart failure., American Heart Association (AHA), $308000, 2009 - 2014.
257. Lymperopoulos, A., Duru, A. Aukszi, B., Targeting of adrenal beta-arrestin1 for prevention and treatrment of tobacco-related, aldosterone-dependent heart disease, Florida Department of Health , $800132, - .
258. Lymperopoulos, A., Beta-arrestin2 Enhances Cardiac Contractility via Promotion of SERCA Activity, NIH, $378390, - .
259. Lymperopoulos, A., Beta-arrestin2 Enhances Cardiac Contractility via Promotion of SERCA Activity, NIH, $378390, 2015 - 2018.
260. Lymperopoulos, A., beta-arrestin2 and SERCA interaction in cardiomyocytes, NSU HPD, $5000, 2015 - 2016.
261. Lymperopoulos, A., Regulation of cardiac SERCA2a activity by beta-arrestin2, , $15000, 2015 - 2016.
262. Lymperopoulos, A., Aukszi, B., Development of a novel angiotensin receptor blocker for heart failure therapy, NSU, $14984, 2016 - 2017.
263. Lymperopoulos, A., test project, NIH, $1000, 2013 - 2014.
264. Lymperopoulos, A., Gao, E., beta-arrestin2-dependent regulation of SERCA & contractility in the failing heart, National Institutes of Health, $880240, 2015 - 2019.
265. Lymperopoulos, A., Angiotensin receptor blockers & beta-arrestin-dependent aldosterone production, NSU President`s Faculty Research and Development Grants, $9661, 2013 - 2014.
266. Lymperopoulos, A., Beta2-Adrenergic Receptor-induced Beta-arrestin2 activation & Glucocorticoid Receptor downregulation, American Asthma Foundation Research Program, $250000, 2013 - 2015.
267. Lymperopoulos, A., Role of beta-arrestin-1 in aldosterone production from adrenocortical cells, NSU HPD, $5000, 2011 - 2012.
268. Lymperopoulos, A., Role of Adrenal GRK2 in Regulation of Sympathetic Nervous System Activity in Heart Failure, American Heart Association (AHA), $41000, 2007 - 2008.
269. Lymperopoulos, A., Role of Adrenal GRKs in Regulation of Sympathetic Nervous System Activity in Heart Failure., American Heart Association (AHA), $76000, 2005 - 2007.
270. M Carbonell, D Mastropietro, Acceptance and Efficacy of Gummy Oral Sedative by Pediatric Patients, Health Professions Research Grant , $4300, 2019 - 2019.
271. M.Amiji, M.Trivedi, Metabolic and Molecular Reprogramming of cancer stem cells using Nanovectors., National Cancer Institute, $299852, 2017 - 2018.
272. M.Clark, M.Trivedi., O'Connor, A., Role of D4 receptor in Renin Angiotensin System in spontaneous hypertensive rats., NSU Presidential Fellowship , $15000, 2017 - 2018.
273. M.Trivedi, Ravindran, G. R., ME/CFS in a Petri-dish., Non-profit organization Solve ME/CFS Initiative, $30000, 2019 - 2019.
274. M.Trivedi, R.Deth, Effects of casein-derived Opioid peptides on redox status and oxidative stress in Neurons., The a2 corporation , $180000, 2013 - 2017.
275. M.Trivedi, Redox mediated Epigenetic changes by casein-Opioid peptides in autism spectrum animal model., The a2 corporation , $30000, 2016 - 2016.
276. M.Trivedi, Redox-Epigenetic Changes in Neuronal Stem Cell differentiation., NSU Presidential Fellowship , $15000, 2017 - 2018.
277. Machado C, Zapantis A, Singh-Franco D., Marsh WA, Beckey C, Ortiz B., Evaluation Of The Impact Of Faculty-Mediated Interventions On Pharmacy Students Postgraduate Interests., Nova Southeastern University_Intramural Research and Development Grant, $2500, 2005 - 2005.
278. Maclean, C., Popovici, I., French, M., Effect of substance use disorder treatment on maternal substance use and birth outcomes: An econometric analysis., NIH (NIDA), $140000, 2017 - 2017.
279. Maclean, C., Popovici, I., French, M.T., Simon, K., Messiah,, S., Effect of substance use disorder treatment on maternal substance use and birth outcomes: An econometric analysis., NIH (NIDA), $141246, 2018 - 2018.
280. Maclean, C., Popovici, I. (sub-PI), French, M., The Effect of Expanding SUD Treatment Availability on Maternal Substance Use and Birth Outcomes, NIH (National Institute on Drug Abuse), $500000, 2017 - 2017.
281. Maclean, J.C., Popovici, I. (sub-PI), French, M., Thomas, S., Alcohol Prevention Policies, Maternal Alcohol Use, and Health: An Econometric Analysis., National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism), $611407, 2014 - 2014.
282. Madzhidova, S., Hale G, Miller, J., Hypertension risk in pediatric patients receiving ADHD therapy., NSU Health Professions Division Research Committee, $2040, 2016 - 2016.
283. Maniscalco, M., Torres, R., Medication Therapy Management Services: A survey of knowledge and attitudes of community pharmacist practicing in Florida, APhA Foundation Practitioners Innovation in Pharmaceutical Care, $1000, 2006 - 2006.
284. McCollister, K., French, M., Popovici, I., Balsa, A., Homer, J., Economic Evaluation of Screening and Brief Intervention for Problem Drinkers., NIH (National Institute on Alcohol Abuse and Alcoholism), $0, - .
285. McLean, H., Clark, M., Development of Novel Potent Yet Safer Anti-inflammatory Steroids, Presidents Faculty Research and Development Grant, $10000, 2013 - 2014.
286. Michael French, University of Miami, Ioana Popovici, Nova Southeastern University Pierre Alexandre, Johns Hopkins University Isabelle Beulaygue, University of Miami Kathryn McCollister, University of Miami Bisma Sayed, University of Miami, System Modality Study., Florida State Department of Children and Families, $398897, 2009 - 2011.
287. Michael French, University of Miami, Ioana Popovici Jenny Homer, University of Miami Catherine Maclean, University of Miami, Economic Evaluation Methods: Development and Applications., National Institutes of Health, National Institute on Drug Abuse, $3161675, 2005 - 2010.
288. Michael French, University of Miami, Ioana Popovici Jenny Homer, University of Miami Catherine Maclean, University of Miami, Economic Consequences of Alcohol Use Disorders., National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, $1250000, 2006 - 2009.
289. Michael French, University of Miami, Ioana Popovici Kathryn McCollister, University of Miami Maria Davalos, University of Miami, Youth and Adult Economic Impact Study, Florida State Department of Children and Families, $311848, 2008 - 2010.
290. Miller P., Caballero J. (subcontractor/partner), Senior Health: Now!, United Way (DEFERRED), $750000, 2010 - 2011.
291. Miroslav Gantor (FIU), Appu Rathinavelu, Enhancing the Activity of Anticancer Drugs by a Natural Product - Phycocyanin, James and Esther King Biomedical Research Program and Bankhead-Coley Cancer Research Program, $100000, 2013 - 2014.
292. Mohammad S Shawaqfeh, Harrington, C., Gillette, M., Hajar, Z., Sircar-Ramsewak, F., SYSTEMATIC REVIEW OF PHARMACY COMPOUNDING OF PAIN MEDICATION., IACP foundation, $5000, 2013 - 2014.
293. Moreau, C., Schneller, M., Prados, Y., Hale, G., Joseph, T., Seamon, M.J., & Jones, R.S., Advancing interprofessional education in emerging healthcare models, National Association of Chain Drug Stores (NACDS), $20000, 2017 - 2019.
294. Moreau, C., Steinberg, J.G., Spaced Testing to Enhance Students' Preparations for Pharmacy Law Board Examination, American Association of Colleges of Pharmacy (AACP), $10000, 2019 - 2020.
295. Morris, M., Latimer, J.J., Short-Term Enhancement research Training Program for Under-served Populations (STEP-UP), NIH, $1294110, 2018 - 2023.
296. Morris, M., Oviawe, Latimer, J.J. Speth, Beljanski, Gamification: Emerging Techniques in Biomedical Research Training (GET)., PENDING: National Institutes of Health, $2448425, 2020 - 2025.
297. Morris, M., Latimer, J.J., Gamification: Emerging Techniques in Biomedical Research Training (GET)., US DHHS National Institutes of Health, $2159775, 2019 - 2021.
298. Morrow, T, Dunbar, S, Levin, A.D., Fritzinger-Hearn L, Herman A, Sanchez M, Pizzimenti J, Stern D, Nehmad L, Feldman H, Vargas P, Andrews J, Hollar L, Lynch J, Albert S., Interprofessional Diabetes Education and Awareness Initiative: Impacting Diabetes in Broward County through Interprofessional Collaborations., Nova Southeastern University, $10000, 2015 - 2015.
299. Mutasem Qalaji, Syed A. A. Rizvi, In Vivo Testing and Analysis of Two Proprietary Transdermal Formulations, Gensco Laboratories, $41490, 2014 - 2015.
300. Nada AH, Krishnaiah YSR, Zaghloul AA, Khattab I, Evaluation of vitamin E-containing cosmetic products marked in Kuwait, Kuwait University Research Administration, Kuwait, $22000, 2006 - 2009.
301. Nakagawa N., Lai, L., Pharmacist Perception of Clinical Literature Accessibility Survey - Japan vs. USA, Japanese Society of Drug Informatics, $2000, 2014 - 2015.
302. Negussie, S.,, Clark, M., Role Of Beta-arrestins In Ang II-Mediated Signaling In Rat Astrocytes., Health Professions Division Research Grant, $5000, 2015 - 2017.
303. Novoa, G., Lai, L., Quality of Life for Hypertension Disease Management Project., Parke Davis Pharmaceuticals, $120000, 1999 - 2002.
304. O'Keefe, D, Latimer, JJ (co-investigator), Understanding the Role of FOLH1 in Advanced Breast Cancer to Enhance Targeted Therapies, DOD CDMRP, $400000, 2018 - .
305. OH, T, Lai, L., The Pharmacoeconomics of Cardiovascular Outcomes with COXIBS and NSAIDS at CIGNA of Florida: A Retrospective Assessment, Pharmacia Pharmaceutical, Inc., $50000, 2002 - 2004.
306. OH, T., Lai, L., Differences in the Clinical Outcomes and Pharmacoeconomic Aspects of COX-2 Inhibitors and NSAIDS in a Managed Care Population., Pharmacia Pharmaceutical company, $40000, 2002 - 2004.
307. P Aung Gyi, M Espinoza-Friedman, A Zapantis, W Kernan, Pharmacy intervention on reduction of early readmission rate in COPD patients., Florida Society of Health-Systems Pharmacists, $7500, 2013 - 2013.
308. Pandya N, Caballero J. (discipline head), Geriatric Research and Education and Training Center (GREAT GEC), Health Resources and Services Administration (AWARDED), $2100000, 2010 - 2016.
309. Perez A, Elrod S, Sanchez J, Proportion Of Patients With Uncontrolled Type 2 Diabetes Receiving Recommended Diabetes Treatment Among Whites and Mexican Americans in the United States: NHANES 2003-2010., Nova Southeastern University Health Professions Division, $1400, 2013 - 2014.
310. Perez A., American Association of Diabetes Educators (Karen Fitzner, PhD.), Integration of diabetes self-management education and training (DSME/T) into patient centered medical home demonstration project. (Role: consultant methodologist/statistician), American Association of Diabetes Educators, $21000, 2011 - 2012.
311. Perez, A., Singh-Franco, D., Suciu, G., Walton, S., Design of a Decision Analysis Model with Representative Inputs for the Hispanic/Latino Population and Comparison of Costs and Effectiveness with the non-Hispanic white population in the United States. Grant not awarded, project not developed., American Association of Colleges of Pharmacy New Pharmacy Faculty Research Awards Program for Pharmacy Faculty., $0, 2010 - .
312. Prochownik, Latimer, J.J., Novel Drugs Targeting Breast Cancer Stem Cells., UPCI Hillman Fund, $250000, 2011 - 2012.
313. Pulhalla, Latimer, J.J., PARP Inhibitor Treatment of Triple Negative Breast Cancer., The Shapira Foundation, $100000, 2010 - 2012.
314. R Ahmad, H Omidian, Deterring Drug Abuse via Injection Utilizing Crosslinked Starch, , $ (Funded), Feb 2017., HPD Grant, Nova Southeastern University, $5000, 2017 - 2017.
315. R.A. Ansari, Saleem Khan, Estrogenic Potential of Xenoestrogens, NIH, $875000, 2001 - 2006.
316. R.A. Ansari, None, Estrogenic Potential of Xenoestrogens, National Institute of Environmental Health Sciences, $875000, 2002 - 2007.
317. R.A. Ansari, None, Nuclear Transcription in Xenoestrogens' induced Prostatic Hyperplasia, Arnold Mabel Beckman Foundation, $40000, 2002 - 2003.
318. R.A. Ansari, None, Regulation of human angiotensinogen gene transcription by sterol regulatory element binding protein, American Heart Foundation, $240000, 2004 - 2008.
319. Rabionet S, Zorrilla, C. (PI), University of Puerto Rico Mentoring Institute for HIV and Mental Health Research., NIHM, $1250000, 2016 - 2021.
320. Rabionet SE., Castejon, A.M., Perez, A., Calderon, J.L., McLaughlin-Middlekauf, J., Alvarez, G., Alvarado, M., Diabetes literacy and self-efficacy screening and training project (Project DLASST)., Centers for Medicare and Medicaid Services, $225000, 2009 - 2011.
321. Rabionet, S., Perez, A. Carvajal, M., Clauson, K., Armayor, G.M., McLaughlin-Middlekauff, J., Factors affecting HPV vaccine acceptability: A comparison of Hispanic subgroups. Grant not awarded, project not developed., Chancellor's Faculty Research & Development Grant, $0, 2010 - .
322. Rabionet, S., Zorrilla, C. (PI), ARRA Pilot Project and Expansion of the UPR Mentoring Instittue for HIV and Mental Health Related Research., National Institute of Mental Health , $389000, 2009 - 2011.
323. Rabionet, S., Zorrilla, C. (PI), Workfroce Development for Training and Partnership Creation for Translational Research, NIH National Center for Research Resources, $195800, 2009 - 2011.
324. Rabionet, S.; Jove, R., Latimer, J J. Perez, A. Beljanski, V. Gannett, P. Sanchez, J., Center for Minority Research on Chronic Diseases., NIMHD, $7500000, 2019 - 2024.
325. Rabionet, S.; Jove, R., Latimer, J J. Perez, A. Beljanski, V. Gannett, P. Sanchez, J., Center for Minority Research on Chronic Diseases., NIMHD,, NIH, $7500000, 2018 - 2023.
326. Rabionet, S.; Jove, R., Mentors and investigators from the College of Pharmacy, College of Medicine, and other science divisions in the university., Center for Minority Research on Chronic Diseases., NIMHD, $7500000, 2019 - 2024.
327. Rawas-Qalaji, M.M., Yoo, D., Quantification of Xylitol Released From Tooth Wipes in an In Vitro Experiment., HPD, $5000, 2011 - 2012.
328. Rawas-Qalaji, M.M., List of All Pre-IND Filling, Funded and Unfunded Grants and Contracts, , $1, - .
329. Rawas-Qalaji, M.M., Rachid, O.M., Simons, K.J., Simons, E.R., License Contract for Patents related to “Epinephrine Nanoparticles, Methods of Fabrication Thereof, and Methods for Use Thereof for Treatment of Conditions Responsive to Epinephrine (NSUI0-0l)” (Pending Negotiations)., Norgine Ltd., $0, 2014 - .
330. Rawas-Qalaji, M.M., Rizvi, S., In Vivo Testing and Analysis of Two Transdermal Formulations.(Pending Finalizing Agreement), Gensco Laboratories , $41490, 2014 - 2014.
331. Rawas-Qalaji, M.M., Assessment of Hair Product Formulation – Phase 1, Biologix Hair, Inc, $27340, 2013 - 2014.
332. Rawas-Qalaji, M.M., Simons, K., Simons, E., Gu, X., License Contract for US Patent Applications # 20070059361 and 20070202163, and International Patent Applications “PCT” # PCT/CA2006/001472 and PCT/CA2008/000197., Verus Pharm, $7900000, 2006 - .
333. Rawas-Qalaji, M.M., Rachid, O., Nanocrystals of Epinephrine in Sublingual Tablets: A Potential Non-Invasive, First-Aid, Life-Saving Treatment of Anaphylaxis (Pending Scoring - March 2014), Canadian Institutes of Health Research (CIHR), $140000, 2014 - 2016.
334. Rawas-Qalaji, M.M., Ophthalmic drug formulation and delivery, Natural Sciences and Engineering Research Council (NSERC), $60000, 2007 - 2008.
335. Rawas-Qalaji, M.M., Formulation and diffusion of epinephrine’s prodrug for anaphylaxis treatment, President’s Faculty Research and Development Grant, $10000, 2013 - 2014.
336. Rawas-Qalaji, M.M., Sublingual Epinephrine Tablets for the Non-Invasive Emergency Treatment of Anaphylaxis (Not Funded)., AACP, $10000, 2010 - 2011.
337. Rawas-Qalaji, M.M., Feasibility of Epinephrine's Prodrug for Anaphylaxis Treatment: Proof of Concept (was not approved by the Dean due to limited use of animal facility space), President's Faculty Research & Development Grant (PFRDG), $10000, 2012 - 2013.
338. Rawas-Qalaji, M.M., Sublingual Epinephrine Tablets for the Non-Invasive Emergency Treatment of Anaphylaxis (Not Funded/Award was put on hold due to bad economy)., AACP, $10000, 2009 - 2010.
339. Rawas-Qalaji, M.M., Novel approach for the Drug Delivery of Epinephrine for Anaphylaxis Treatment (extended to Dec. 2011)., President's Faculty Research & Development Grant (PFRDG), $10000, 2009 - 2011.
340. Rawas-Qalaji, M.M., Sublingual Epinephrine Tablets for the Non-Invasive Emergency Treatment of Anaphylaxis., HPD, $5000, 2008 - 2009.
341. Robert C. Speth, Please refer to NIH biosketch in other scholarly activities which contains information on current grant funding., , $1, 2013 - 2017.
342. Robert C. Speth, Combined file of grant history is in "Other Scholarship Activities" directory in file named 171214 Grant Funding record at NSU for continuing contract, , $1, 2010 - 2017.
343. Robert Speth, Clark, M., Brain specific non-AT1, non-AT2 angiotensin binding site, The National Heart, Lung, and Blood Institute, $369000, 2009 - 2011.
344. Rosenkranz, H., Grant, S.G., & Macina, O., Evaluation of Specific Hazardous Air Pollutants for Developmental Toxicity using QSAR., Environmental Protection Agency, $95000, 1997 - 1998.
345. Rumbaugh Goodwin Institute for Cancer Research, Appu Rathinavelu, The funding is provided to support the Drug Discovery program and Translational Research at RGI, Royal Dames of Cancer Research Inc., $1200000, 2007 - 2016.
346. S Alaei, R Ahmad, H Omidian, Deter IV Drug Abuse Using Cross-Linked Acrylate Polymers, Nova Southeastern University, $7500, 2018 - 2020.
347. S Wright, D Mastropietro, Acceptance of Gummy Oral Sedative by Patients With Autism Spectrum Disorder (ASD), Health Professions Research Grant, $3225, 2019 - 2019.
348. S.Murray, M.Trivedi, Epigenetic changes in T cell regulation., NSU Presidential Fellowship , $15000, 2016 - 2017.
349. Sanderson M, Day RS, Briones E, Benavides S, Millard A, Mier N, Flores I, Peltz G, Deyhim F, Garcia D, Bogle M, Valley Activity and Nutrition Study (VANS)., National Institutes of Health (NOT FUNDED), $2518897, 2005 - 2005.
350. Sando, K., Hale G, & Moreau, C., Training students for practice- and team-readiness prior to an interprofessional APPE., American Association of Colleges of Pharmacy, $4000, 2018 - 2019.
351. Sangasubana N., Calderon J., Borja, N., Hardigan, P., Rabionet S., & Alvarez, G., Pharmacy Interventions to Improve Generic Over-The-Counter Drug Knowledge and Use, NSU President’s Faculty Research and Development Grant, $10000, 2008 - 2008.
352. Santini E, Co-PI: Dr. Annelyn Torres-Reveron (NSU COP) Collaborator: Dr. Dinah Ramos-Ortolaza (NSU COP) Consultant: Dr. James T. Porter (Ponce School of Medicine), Acute Morphine after Fear learning: Implications for Sex specific PTSD Treatment, Nova Southeastern University, CFRDG grant, $10000, 2011 - 2012.
353. Santini E, Co-PI: Dr. Dinah Ramos-Otolaza, D. Collaborator: Dr. Annelyn Torres-Reveron Consultant: Dr. James T. Porter, The effects of chronic morphine treatment in fear conditioning in male and female rats at different stages of the estrous cycle., Health Profressions Division, NOVA Southeastern University, $5000, 2011 - 2013.
354. Schneller, M., Hale G, & DeMuro, P., What are transformative strategies to measure or evaluate value of health care interventions that could be implemented to advance a value-driven health care system in the United States?, PhRMA Foundation, $50000, 2017 - 2018.
355. Seth, Latimer, J.J., Oncolytic Adenovirus Expressing sTGF RIIFc., U.S. National Institutes of Health/National Cancer Institute , $747403, 2007 - 2010.
356. Shawaqfeh, M., Harrington CA, Khanfar NM, Naturalistic Study of the Clinical Relevance of Pharmacogenetic Testing for Cardiovascular Drug Sensitivity and Vascular Risk., Above and Beyond Medicine., $70000, 2014 - 2014.
357. Shawaqfeh, M., Harrington C, Alvarez, G. Khanfar NM, Pharmacogenetic Testing in Cardiovascular Drug Prescribing: A Pharmacist Initiative, ASHP, $20000, 2016 - 2018.
358. Shawaqfeh, M., Khanfar NM, Harrington C., Health Professions Students Knowledge and Attitudes Towards Pharmacogenomics, HPD Education, $5000, 2015 - 2015.
359. Sherman E, Training program for scientists conducting research to reduce HIV/STI health disparities, University of California San Francisco, Center for AIDS Prevention Studies (NOT FUNDED), $25000, 2012 - 2015.
360. Sherman E, Schweizer M, Worley M, AIDS Education and Training Centers Program, University of Miami/HRSA (AWARDED), $108320, 2017 - 2018.
361. Sherman E, Schweizer M, Worley M, AIDS Education and Training Centers Program, University of Miami/HRSA (AWARDED), $102000, 2016 - 2017.
362. Sherman E, Beal J, Schweizer M, AIDS Education and Training Centers Program, University of Miami/HRSA (AWARDED), $134180, 2015 - 2016.
363. Sherman E, Schweizer M, Florida/Caribbean AIDS Education and Training Center (AETC), University of South Florida/HRSA (AWARDED), $72857, 2014 - 2015.
364. Sherman E, Elrod S, Illustrated medication schedules to optimize HIV treatment response, NSU President's Faculty Research and Development Grant (NOT FUNDED), $10000, 2012 - 2013.
365. Sherman E, Clauson K, Ayala K, Alkhateeb F, Eckardt P, A randomized controlled trial evaluating the use of daily short message system (SMS) text message reminders to increase antiretroviral adherence in a primary care specialty clinic., NSU Health Professions Division Research Grant (AWARDED), $5000, 2011 - 2013.
366. Sherman E, Clauson, K., Ayala, K., Eckardt, P., Alkhateeb, F., Evaluating the benefits of text message reminders on HIV medication adherence., NSU Chancellor's Faculty Research and Development Grant (AWARDED), $10000, 2011 - 2013.
367. Sherman EM, Gauthier TP Unger NR, Developing a novel interprofessional antimicrobial stewardship elective course (NOT FUNDED), Nova Southeastern University Health Profession Divisions, $5000, 2013 - 2014.
368. Silva-Suarez G, Rabionet S, Student pharmacist experiences and campus response in the aftermath of Hurricane Maria., NSU-HPD, $5000, 2018 - 2019.
369. Silva-Suarez, G., Alvarado Y Colon-Pratts,F. Ayala, K. Arce, L. Lozada, R., Optimizing antiretroviral adherence among a group of womenliving with HIV in Puerto Rico: A pilot study, Health Profession Division , $7480, 2017 - 2018.
370. Silva-Suarez, G., Rabionet, S., Hurricane-related maternal stress, infant outcomes, and resilience factors. (Subcontract with NSU), NSU-HPD, $275000, 2018 - 2020.
371. Silva-Suarez, G., Alvarado, Y., Medina, P., Lozada, R., Ortiz, B. & Rabionet, S., Student pharmacist experiences and campus response in the aftermath of Hurricane Maria: a mixed-method approach, Health Profession Division Grant Office , $5078, 2018 - .
372. Silva-Suarez, G., Zorrilla, C., Working Together: An Interdisciplinary Approach to Reduce Pill Burden and Optimizing HAART among Women Living With HIV in Puerto Rico, Gilead Science Research Scholars Program in HIV, $128672, 2016 - 2017.
373. Silvia Rabionet, Popovici, I., Gershman, J., Sanchez, J., & Perez, A., Nonmedical Use of Prescription Drugs among Health Professions Students: Development of an Assessment Instrument., Nova Southeastern University Health Professions Division, $5000, 2012 - 2013.
374. Silvia Rabionet, Rawas-Qalaji, M.M., Summer Research Experience (Not Funded), NIMH-NIH (R25), $0, 2012 - 2013.
375. Singh-Franco D, Lai, L., Diamond, M., Hannah, S., Impact of a pharmaceutical care program to congestive heart failure patients, President's Faculty Scholarship Award, $9599, 2003 - 2003.
376. Singh-Franco D, Lai L, Hannah S, Diamond M, Evaluation of a Pharmaceutical Care Service Program for Congestive Heart Failure Patients., President's Faculty Scholarship Award, $9598, 2003 - 2003.
377. Singh-Franco D., Lai L, Hannah S, Diamond M., An Outcome Evaluation of a Pharmaceutical Care Service Program to Congestive Heart Failure Patients., President's Faculty Research and Development Grant, $9598, 2002 - 2003.
378. Snyder M., Alissa Russ, PhD; Wendy Lantaff, PharmD; Heather Jaynes, RN, MSN; Bill Doucette, PhD, FAPhA, RPh; Gernant, S.A., Enhancing Clinical Decision Support Applications for Community Pharmacist-Delivered Medication Therapy Management., Agency for Healthcare Research and Quality, US Department of Health and Human Services, $224116, 2016 - .
379. Speth R, Lymperopoulos, A., Development of an angiotensin II-conjugate as a biased agonist at AT1 receptors, NSU, $15000, 2015 - 2016.
380. Steinberg, J.G., Moreau, C., Use of an Interactive Spaced Education and Testing Platform in a Pharmacotherapy Course Sequence, Nova Southeastern University, $10000, 2017 - 2018.
381. Stultz, K, D Mastropietro, M.Trivedi, Riskin, JW, Strategic opportunities for improved patient care via interdisciplinary nutrition and culinary training for pharmacy students., National Association of Chain Drug Stores (NACDS)Foundation , $20000, 2018 - 2019.
382. Syed A. A. Rizvi, Ansari, R.A., Crystal Engineering Strategy for Prevention of Hepatotoxicity, President's Grant, $10000, 2012 - 2013.
383. Syed A. A. Rizvi, Prof. Fred M. Menger, Investigation of Cell/Lipid interaction in Monolayer Films, National Science Foundation (NSF), $120000, 2009 - 2011.
384. Syed A. A. Rizvi, Cocrystallization and Formulation Strategies for Low Bioavailability Drugs, American Association of Colleges of Pharmacy (AACP), $10000, 2012 - 2012.
385. Syed A. A. Rizvi, Cocrystallization studies of Amiodarone, HPD, $5000, 2012 - 2014.
386. Tavakoli, S, Latimer, JJ Beljanski Nathanson Trivedi, Epigenetic Profiling for Improvement of Therapeutic Responses, DOD CDMRP, $368650, 2018 - 2019.
387. Tavakoli, S., Latimer, J.J., Single Cell Sequencing and Epigenetic Profiling as Diagnostic Tools for Optimization of Cancer Therapies, Bankhead-Coley Cancer Research Program, $246387, 2018 - 2019.
388. Tavakoli, S., Latimer, J.J., Epigenetic Profiling for Improvement of Therapeutic Responses., U.S. Department of Defense, $368650, 2019 - 2020.
389. Tenam-Zemach, M., Huang, HF., Desir, C., Simonetti, C., Chenail, R., Lai, L., Content Analysis of Environmental Sustainability Themes in Florida Standards, Nova Southeastern University Chancellor’s Annual Faculty Research and Development Grant, $6740, 2009 - 2010.
390. Torres-Reveron, A., Milner, T.A., Estrogen-Opioid Interactions in Hippocampus, NIH-NIDA, $0, 2005 - 2008.
391. Torres-Reveron, A., Role of Ovarian Hormones in the Development of Depression Using a Rat Model., Nova Southeastern University, CFRDG grant, $10000, 2010 - 2012.
392. Torres-Reveron, A., Estrogen modulation of neurotrophin and opioid systems in the female hippocampus., Nova Southeastern University, HPD Grant, $5000, 2010 - 2012.
393. Trivedi, M, Clark, M., Speth, R., Interaction of the AT1R and the D4R in Cultured Neurons., Presidents Faculty Research and Development Grant, $15000, 2016 - .
394. U Kandalam, T Kawai, S Kaltman, M Clark, H Omidian, Regeneration of Vascularized Bone from Ex Vivo Programmed Gingival Stem Cells, NIDCR R15, $346187, 2017 - 2017.
395. U. Kandalam, H. Omidian, A. Cabel, S. Mccarthy, E. Stelnicki, Alginate hydroxyapatite nanocomposite scaffolds for bone tissue engineering, President's Grant, $10000, 2010 - 2011.
396. UD Kandalam, MA Clark, H Omidian, MA Duarte, AE Saltz, In Vitro Evaluation of an Injectable Tissue-Engineered Nano-Composite Scaffolds, Nova Southeastern University, $10000, 2012 - 2013.
397. Unger N, Sherman E, Community pharmacist knowledge of, experiences with, and attitudes toward over-the-counter rapid HIV testing (NOT FUNDED), Campbell Foundation Grant, $20000, 2013 - 2014.
398. Unger NR, Robert Borrego Erich Ritter Olayemi O. Osiyemi Jay Goodman, Oral bacterial flora and antimicrobial susceptibilities of Florida sharks: guidance for antimicrobial therapy., Nova Southeastern University Health Professions Division, $4892, 2013 - 2015.
399. V.Beljanski, M.Trivedi., Nathanson, L., Modulation of therapeutic cells exosome content by autophagy., NIH National Institute of General Medical Sciences , $454924, 2018 - 2021.
400. Vogel, V., Latimer, J.J., Breast Cancer Live Cell Video for Subdividing Same-Stage Tumors., Jewish Healthcare Foundation of Pittsburgh/Aronsen Foundation , $59614, 1998 - 2000.
401. Wolowich W.R., Physiologically -Based Pharmacokinetic Modeling, Certara-Simcyp, $30000, 2016 - 2017.
402. Wolowich WR, Greif R, Kleine-Brueggeney M, Bernhard W, Sachs H, Theiler L., An Improved Nonlinear Mixed Effects Pharmacokinetic Model Of Intravenously Applied D9-Tetrahydrocannabinol (THC) And Metabolites In Volunteers., University of Bern, Switzerland, $5000, 2013 - 2014.
403. Wolowich WR, The Compatibility and Stability of Pralidoxime in Intravenous Solutions and Admixtures, Nova Southeastern University Health Profession Division – Research Committee, $2500, 2005 - 2006.
404. Wolowich WR, Pharsight (Certara) Academic Licensing Program (PAL) Software grant Pharsight WinNonlin®, Pharsight WinNonMix™, Pharsight Trial Simulator™., Certara, $30000, 2008 - 2017.
405. Wolowich WR, Min, B, The Impact of Coenzyme Q10 Level on Acute Rejection in Cardiac Transplantation, NSU Presidents Grant, $10000, 2008 - 2010.
406. Wolowich WR, Levy L, Gagnon-Blodgett M, Rokusek C, Geriatric Education Center, Health Resources and Services Administration (HRSA), $30000, 2008 - 2011.
407. Wolowich, WR, Pharsight Academic Licensing Program (PAL)., Pharsight Inc., $20000, 2007 - 2011.
408. Yellela S.R. Krishnaiah, Penetration enhancing effect of geraniol and fenchone on transdermal permeation of flurbiprofen, HPD Grant, $5000, 2009 - 2011.
409. Yugandhar, V.G., Clark, M., Ang II Effects on MMP-9 and Collagen Levels in Hypertensive Rat Astrocytes., Presidents Faculty Research and Development Grant, $10000, 2014 - 2016.
410. Yugandhar, V.G.,, Clark, M., Central Mechanisms of Angiotensin II in Hypertensive Rat Astrocytes., Presidents Faculty Research and Development Grant, $10000, 2012 - 2013.
411. Zorrilla C, Rabionet S, Mentoring Institute for HIV and Mental Health Research, NIHM, $1250000, 2008 - 2021.
412. Zorrilla C, Rabionet S, Adherence to ART: A Trans-Caribbean Study, NIAID, $500000, 2013 - 2018.
413. Zorrilla, C., Silva-Suarez, G. & Rabionet, S., Adherence to Highly Active Anti-Retroviral Therapy (HAART): a Trans-Caribbean Study., National Institute of Allergy and Infectious Diseases, $0, 2013 - 2015.